Similar articles

• Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome.

  Pilarski R, Eng C. Pilarski R, et al. J Med Genet. 2004 May;41(5):323-6. doi: 10.1136/jmg.2004.018036. J Med Genet. 2004. PMID: 15121767 Free PMC article. Review. No abstract available.
• Absence of germline mutations in MINPP1, a phosphatase encoding gene centromeric of PTEN, in patients with Cowden and Bannayan-Riley-Ruvalcaba syndrome without germline PTEN mutations.

  Dahia PM, Gimm O, Chi H, Marsh DJ, Reynolds PR, Eng C. Dahia PM, et al. J Med Genet. 2000 Sep;37(9):715-7. doi: 10.1136/jmg.37.9.715. J Med Genet. 2000. PMID: 11182934 Free PMC article. No abstract available.
• PTEN hamartoma tumour syndrome: variability of an entity.

  Merks JH, de Vries LS, Zhou XP, Nikkels P, Barth PG, Eng C, Hennekam RC. Merks JH, et al. J Med Genet. 2003 Oct;40(10):e111. doi: 10.1136/jmg.40.10.e111. J Med Genet. 2003. PMID: 14569134 Free PMC article. No abstract available.
• Two novel mutations of PTEN gene in Japanese patients with Cowden syndrome.

  Sawada T, Okada T, Miwa K, Satoh H, Asano A, Mabuchi H. Sawada T, et al. Am J Med Genet A. 2004 Jul 1;128A(1):12-4. doi: 10.1002/ajmg.a.20309. Am J Med Genet A. 2004. PMID: 15211648
• [Cowden disease and the PTEN gene: a successfully clinical and biological combined approach].

  Longy M. Longy M. Bull Cancer. 2001 Dec;88(12):1153-8. Bull Cancer. 2001. PMID: 11792608 Review. French.